Our top pick for
Sensus Healthcare, Inc is a medical devices business based in the US. Sensus Healthcare shares (SRTS) are listed on the NASDAQ and all prices are listed in US Dollars. Sensus Healthcare employs 53 staff and has a trailing 12-month revenue of around USD$13 million.
|Latest market close||USD$3.63|
|52-week range||USD$1.7603 - USD$4.99|
|50-day moving average||USD$2.7191|
|200-day moving average||USD$2.7713|
|Wall St. target price||USD$4.43|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.152|
|1 week (2021-01-07)||-17.50%|
|1 month (2020-12-15)||-19.33%|
|3 months (2020-10-15)||30.58%|
|6 months (2020-07-15)||21.00%|
|1 year (2020-01-15)||-10.37%|
|2 years (2019-01-15)||-54.63%|
|3 years (2018-01-13)||N/A|
|5 years (2016-01-13)||N/A|
|Revenue TTM||USD$13 million|
|Gross profit TTM||USD$17.6 million|
|Return on assets TTM||-14.77%|
|Return on equity TTM||-28.86%|
|Market capitalisation||USD$51.5 million|
TTM: trailing 12 months
There are currently 188,789 Sensus Healthcare shares held short by investors – that's known as Sensus Healthcare's "short interest". This figure is 0.9% down from 190,443 last month.
There are a few different ways that this level of interest in shorting Sensus Healthcare shares can be evaluated.
Sensus Healthcare's "short interest ratio" (SIR) is the quantity of Sensus Healthcare shares currently shorted divided by the average quantity of Sensus Healthcare shares traded daily (recently around 13621.13997114). Sensus Healthcare's SIR currently stands at 13.86. In other words for every 100,000 Sensus Healthcare shares traded daily on the market, roughly 13860 shares are currently held short.
However Sensus Healthcare's short interest can also be evaluated against the total number of Sensus Healthcare shares, or, against the total number of tradable Sensus Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sensus Healthcare's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Sensus Healthcare shares in existence, roughly 10 shares are currently held short) or 0.0166% of the tradable shares (for every 100,000 tradable Sensus Healthcare shares, roughly 17 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Sensus Healthcare.
Find out more about how you can short Sensus Healthcare stock.
We're not expecting Sensus Healthcare to pay a dividend over the next 12 months.
Over the last 12 months, Sensus Healthcare's shares have ranged in value from as little as $1.7603 up to $4.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sensus Healthcare's is 0.1708. This would suggest that Sensus Healthcare's shares are less volatile than average (for this exchange).
Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.